VERU: Wutah dodolan triwulanan Veru Inc.

Logo korporat perusahaan Veru Inc (VERU)

The implementation of software robots for clinical data analysis accelerates drug time-to-market, which underscores the quarterly revenue growth rate for Veru Inc. (VERU). The 0.00 mark indicates the level of current dynamics. Success is based on a closed-loop support system for oncological urology patients and the integration of women's health solutions, creating an expert portfolio of specialized therapeutic brands.

Veru Inc (VERU) - Tambahing pendapatan triwulanan saka 04.07.2022 nganti 20.11.2026

Rincian metrik keuangan lan pasar Veru (VERU)

- kuotasi saiki lan rata-rata prakiraan nilai:
- informasi kapitalisasi pasar:
Analisis wiwitan perusahaan:verupharma.com - VERU
Produk seri verupharma.com

The specifics of Veru Inc. (VERU) within the oncology sector ensure resilient demand, where the primary risk shifts from macroeconomics to R&D success and patent expiration dates. The percentage change in quarterly revenue measures the rate of income growth over three months, allowing investors to distinguish an active scaling phase from the stagnation of a mature asset through comparable percentage analysis.

Pesaing Veru Inc.

BeiGene Oncology - Wutah pendapatan triwulanan|HALO: Wutah pendapatan kuartal marang kuartal|Revolution Medicines Corp (RVMD) - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Ascentage Pharma Group International (AAPG)|Wutah pendapatan kuartal marang kuartal CG Oncology, Inc.|Tingkat wutah pendapatan sajrone kuartal UroGen Pharma Corp URGN|Wutah pendapatan triwulanan BCAX|Personalis, Inc. - Wutah dodolan kuartal marang kuartal|Erasca - Wutah dodolan triwulanan|Tambahing pendapatan triwulanan DCTH|YMAB: Wutah dodolan triwulanan|Tingkat wutah pendapatan sajrone kuartal Aura Corp|CADL: Wutah pendapatan triwulanan|ARAY - Tingkat wutah dodolan sajrone kuartal|SLS (SELLAS Life Sciences Group, Inc.) - Wutah pendapatan triwulanan|ACTU: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal citiusonc.com (CTOR)|Tingkat wutah dodolan sajrone kuartal TuHURA Biosciences|Wutah pendapatan kuartal marang kuartal Protara Therapeutics TARA|Fate Therapeutics (FATE) - Tingkat wutah pendapatan sajrone kuartal|WHWK - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal TScan Therapeutics Inc|championsoncology.com (CSBR) - Wutah pendapatan kuartal marang kuartal|Wutah dodolan kuartal marang kuartal XBIT|Wutah dodolan triwulanan CVM|Wutah dodolan kuartal marang kuartal OSTX (OS Therapies Incorporated)|Wutah pendapatan triwulanan RADX|ARTV: Dinamika pendapatan kuartal marang kuartal|Wutah pendapatan triwulanan ANL (Adlai Nortye Ltd)|Owah-owahan dodolan kuartal marang kuartal TPST (Tempest Tx)|XLO: Wutah dodolan triwulanan|renovarobio.com (RENB) - Wutah dodolan triwulanan|Mural Bio (MURA) - Wutah pendapatan kuartal marang kuartal|Kairos Pharma Inc (KAPA) - Wutah pendapatan triwulanan|Wutah dodolan triwulanan OKUR|CytoMed Therapeutics (GDTC) - Tingkat wutah dodolan sajrone kuartal|Wutah dodolan triwulanan CRIS (Curis Inc.)|Wutah pendapatan triwulanan Apollomics Inc. (APLM)|Wutah pendapatan kuartal marang kuartal Tharimmune Corp THAR|Advanced Biomed Corp - Wutah pendapatan kuartal marang kuartal|GNPX: Wutah dodolan triwulanan|Calidi Biotherapeutics, Inc. (CLDI) - Wutah dodolan triwulanan|SBFM: Wutah pendapatan triwulanan|Wutah dodolan triwulanan Xenetic Biosciences Inc.|Wutah pendapatan kuartal marang kuartal Salarius Pharmaceuticals Inc|PPBT: Tambahing pendapatan triwulanan|Wutah pendapatan triwulanan AONC|BGNE (BeOne Medicines) - Tambahing pendapatan triwulanan|Checkpoint Therapeutics, Inc - Wutah dodolan triwulanan|elevationoncology.com (ELEV) - Tingkat wutah pendapatan sajrone kuartal|iCAD Inc. - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Ikena Oncology|NTBL: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Viracta (VIRX)|MOR (MorphoSys AG) - Wutah pendapatan triwulanan|NAYA: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Ascentage Pharma Group Ltd (AAPGV)